Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 38, 2015, Pages 8407-8417

  Liu, Hung Wen ^a   Chan, Yin Ching ^b   Wang, Ming Fu ^b   Wei, Chu Chun ^a   Chang, Sue Joan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b PROVIDENCE UNIVERSITY   (Taiwan)

Author keywords

aging; EGCG; insulin resistance; senescence accelerated mouse

Indexed keywords

AGING OF MATERIALS; BINS; BIOCHEMISTRY; BIOSYNTHESIS; CHEMICAL ACTIVATION; DIETARY SUPPLEMENTS; FATTY ACIDS; GLUCOSE; INSULIN; METABOLISM; MUSCLE; MUSCULOSKELETAL SYSTEM; NUCLEIC ACIDS; PLANTS (BOTANY); PROTEINS;

EGCG; ELEMENT-BINDING PROTEINS; EPIGALLOCATECHIN-3-GALLATE; INSULIN RESISTANCE; MITOCHONDRIAL BIOGENESIS; PATHOPHYSIOLOGICAL CHANGES; SENESCENCE ACCELERATED MOUSE; STEROL REGULATORY ELEMENT-BINDING PROTEINS;

MAMMALS;

CATECHIN; EPIGALLOCATECHIN GALLATE; GLUCOSE; GLUCOSE TRANSPORTER 4; PLANT EXTRACT; SLC2A4 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

AGING; ANALOGS AND DERIVATIVES; ANALYSIS; ANIMAL; CAMELLIA SINENSIS; CHEMISTRY; DIET SUPPLEMENTATION; DRUG EFFECTS; FATTY LIVER; FEMALE; GENETICS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; METABOLISM; MOUSE; SKELETAL MUSCLE;

AGING; ANIMALS; CAMELLIA SINENSIS; CATECHIN; DIETARY SUPPLEMENTS; FATTY LIVER; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MICE; MUSCLE, SKELETAL; PLANT EXTRACTS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84942862121     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b02501     Document Type: Article

References (44)

1. Liu, H.; Li, J. Aging and dyslipidemia: a review of potential mechanisms Ageing Res. Rev. 2015, 19C, 43-52 10.1016/j.arr.2014.12.001
2. Dillon, L. M.; Rebelo, A. P.; Moraes, C. T. The role of PGC-1 coactivators in aging skeletal muscle and heart IUBMB Life 2012, 64, 231-241 10.1002/iub.608
3. Tchkonia, T.; Morbeck, D. E.; Von Zglinicki, T.; Van Deursen, J.; Lustgarten, J.; Scrable, H.; Khosla, S.; Jensen, M. D.; Kirkland, J. L. Fat tissue, aging, and cellular senescence Aging Cell 2010, 9, 667-684 10.1111/j.1474-9726.2010.00608.x
4. Yu, Y. H.; Ginsberg, H. N. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue Circ. Res. 2005, 96, 1042-1052 10.1161/01.RES.0000165803.47776.38
5. Houtkooper, R. H.; Argmann, C.; Houten, S. M.; Canto, C.; Jeninga, E. H.; Andreux, P. A.; Thomas, C.; Doenlen, R.; Schoonjans, K.; Auwerx, J. The metabolic footprint of aging in mice Sci. Rep. 2011, 1, 134 10.1038/srep00134
6. Takeda, T. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice Neurochem. Res. 2009, 34, 639-659 10.1007/s11064-009-9922-y
7. Takeda, T.; Matsushita, T.; Kurozumi, M.; Takemura, K.; Higuchi, K.; Hosokawa, M. Pathobiology of the senescence-accelerated mouse (SAM) Exp. Gerontol. 1997, 32, 117-127 10.1016/S0531-5565(96)00068-X
8. Butterfield, D. A.; Poon, H. F. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease Exp. Gerontol. 2005, 40, 774-783 10.1016/j.exger.2005.05.007
9. Cuesta, S.; Kireev, R.; Garcia, C.; Rancan, L.; Vara, E.; Tresguerres, J. A. Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8) Age 2013, 35, 659-671 10.1007/s11357-012-9397-7
10. Cohen, J. C.; Horton, J. D.; Hobbs, H. H. Human fatty liver disease: old questions and new insights Science 2011, 332, 1519-1523 10.1126/science.1204265
11. Ye, X.; Meeker, H. C.; Kozlowski, P. B.; Wegiel, J.; Wang, K. C.; Imaki, H.; Carp, R. I. Pathological changes in the liver of a senescence accelerated mouse strain (SAMP8): a mouse model for the study of liver diseases Histol. Histopathol. 2004, 19, 1141-1151
12. Babu, P. V.; Liu, D.; Gilbert, E. R. Recent advances in understanding the anti-diabetic actions of dietary flavonoids J. Nutr. Biochem. 2013, 24, 1777-1789 10.1016/j.jnutbio.2013.06.003
13. Ueda, M.; Nishiumi, S.; Nagayasu, H.; Fukuda, I.; Yoshida, K.; Ashida, H. Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle Biochem. Biophys. Res. Commun. 2008, 377, 286-290 10.1016/j.bbrc.2008.09.128
14. Xiao, J.; Ho, C. T.; Liong, E. C.; Nanji, A. A.; Leung, T. M.; Lau, T. Y.; Fung, M. L.; Tipoe, G. L. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways Eur. J. Nutr. 2014, 53, 187-199 10.1007/s00394-013-0516-8
15. Niu, Y.; Na, L.; Feng, R.; Gong, L.; Zhao, Y.; Li, Q.; Li, Y.; Sun, C. The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats Aging Cell 2013, 12, 1041-1049 10.1111/acel.12133
16. Wolfram, S.; Raederstorff, D.; Preller, M.; Wang, Y.; Teixeira, S. R.; Riegger, C.; Weber, P. Epigallocatechin gallate supplementation alleviates diabetes in rodents J. Nutr. 2006, 136, 2512-2518
17. Bose, M.; Lambert, J. D.; Ju, J.; Reuhl, K. R.; Shapses, S. A.; Yang, C. S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice J. Nutr. 2008, 138, 1677-1683
18. Mehlem, A.; Hagberg, C. E.; Muhl, L.; Eriksson, U.; Falkevall, A. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease Nat. Protoc. 2013, 8, 1149-1154 10.1038/nprot.2013.055
19. Park, J. Y.; Wang, P. Y.; Matsumoto, T.; Sung, H. J.; Ma, W.; Choi, J. W.; Anderson, S. A.; Leary, S. C.; Balaban, R. S.; Kang, J. G.; Hwang, P. M. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content Circ. Res. 2009, 105, 705-712 11 p following 712. 10.1161/CIRCRESAHA.109.205310
20. Fink, R. I.; Kolterman, O. G.; Griffin, J.; Olefsky, J. M. Mechanisms of insulin resistance in aging J. Clin. Invest. 1983, 71, 1523-1535 10.1172/JCI110908
21. Ortsater, H.; Grankvist, N.; Wolfram, S.; Kuehn, N.; Sjoholm, A. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice Nutr. Metab. 2012, 9, 11 10.1186/1743-7075-9-11
22. DeFronzo, R. A.; Gunnarsson, R.; Bjorkman, O.; Olsson, M.; Wahren, J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus J. Clin. Invest. 1985, 76, 149-155 10.1172/JCI111938
23. Sesti, G. Pathophysiology of insulin resistance Best Pract Res. Clin Endocrinol Metab 2006, 20, 665-679 10.1016/j.beem.2006.09.007
24. Houmard, J. A.; Weidner, M. D.; Dolan, P. L.; Leggett-Frazier, N.; Gavigan, K. E.; Hickey, M. S.; Tyndall, G. L.; Zheng, D.; Alshami, A.; Dohm, G. L. Skeletal muscle GLUT4 protein concentration and aging in humans Diabetes 1995, 44, 555-560 10.2337/diab.44.5.555
25. Wang, S.; Moustaid-Moussa, N.; Chen, L.; Mo, H.; Shastri, A.; Su, R.; Bapat, P.; Kwun, I.; Shen, C. L. Novel insights of dietary polyphenols and obesity J. Nutr. Biochem. 2014, 25, 1-18 10.1016/j.jnutbio.2013.09.001
26. Kuzu, N.; Bahcecioglu, I. H.; Dagli, A. F.; Ozercan, I. H.; Ustundag, B.; Sahin, K. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet J. Gastroenterol. Hepatol. 2008, 23, e465-e470 10.1111/j.1440-1746.2007.05052.x
27. Yan, J.; Feng, Z.; Liu, J.; Shen, W.; Wang, Y.; Wertz, K.; Weber, P.; Long, J.; Liu, J. Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate J. Nutr. Biochem. 2012, 23, 716-724 10.1016/j.jnutbio.2011.03.014
28. Li, Y.; Zhao, S.; Zhang, W.; Zhao, P.; He, B.; Wu, N.; Han, P. Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo Diabetes Res. Clin. Pract. 2011, 93, 205-214 10.1016/j.diabres.2011.03.036
29. McGee, S. L.; van Denderen, B. J.; Howlett, K. F.; Mollica, J.; Schertzer, J. D.; Kemp, B. E.; Hargreaves, M. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5 Diabetes 2008, 57, 860-867 10.2337/db07-0843
30. Toledo, F. G. Mitochondrial involvement in skeletal muscle insulin resistance Diabetes 2014, 63, 59-61 10.2337/db13-1427
31. Anderson, R.; Prolla, T. PGC-1alpha in aging and anti-aging interventions Biochim. Biophys. Acta, Gen. Subj. 2009, 1790, 1059-1066 10.1016/j.bbagen.2009.04.005
32. Nakahara, H.; Kanno, T.; Inai, Y.; Utsumi, K.; Hiramatsu, M.; Mori, A.; Packer, L. Mitochondrial dysfunction in the senescence accelerated mouse (SAM) Free Radical Biol. Med. 1998, 24, 85-92 10.1016/S0891-5849(97)00164-0
33. Price, N. L.; Gomes, A. P.; Ling, A. J.; Duarte, F. V.; Martin-Montalvo, A.; North, B. J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J. S.; Hubbard, B. P.; Varela, A. T.; Davis, J. G.; Varamini, B.; Hafner, A.; Moaddel, R.; Rolo, A. P.; Coppari, R.; Palmeira, C. M.; de Cabo, R.; Baur, J. A.; Sinclair, D. A. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab. 2012, 15, 675-690 10.1016/j.cmet.2012.04.003
34. Jiang, T.; Yin, F.; Yao, J.; Brinton, R. D.; Cadenas, E. Lipoic acid restores age-associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1alpha transcriptional pathway Aging Cell 2013, 12, 1021-1031 10.1111/acel.12127
35. Liao, J. W.; Hong, L. Z.; Wang, M. F.; Tsai, S. C.; Lin, Y. J.; Chan, Y. C. Mutagenic safety and fatty liver improvement of nanonized black soybeans in senescence-accelerated prone-8 mice J. Food Sci. 2010, 75, T82-T90 10.1111/j.1750-3841.2010.01638.x
36. Lewis, G. F.; Carpentier, A.; Adeli, K.; Giacca, A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocr. Rev. 2002, 23, 201-229 10.1210/edrv.23.2.0461
37. Ong, K. T.; Mashek, M. T.; Bu, S. Y.; Greenberg, A. S.; Mashek, D. G. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning Hepatology 2011, 53, 116-126 10.1002/hep.24006
38. Rector, R. S.; Thyfault, J. P.; Uptergrove, G. M.; Morris, E. M.; Naples, S. P.; Borengasser, S. J.; Mikus, C. R.; Laye, M. J.; Laughlin, M. H.; Booth, F. W.; Ibdah, J. A. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model J. Hepatol. 2010, 52, 727-736 10.1016/j.jhep.2009.11.030
39. Meng, Q.; Velalar, C. N.; Ruan, R. Regulating the age-related oxidative damage, mitochondrial integrity, and antioxidative enzyme activity in Fischer 344 rats by supplementation of the antioxidant epigallocatechin-3-gallate Rejuvenation Res. 2008, 11, 649-660 10.1089/rej.2007.0645
40. Okatani, Y.; Wakatsuki, A.; Reiter, R. J. Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice J. Pineal Res. 2002, 32, 143-148 10.1034/j.1600-079x.2002.1o106.x
41. Jung, E. J.; Kwon, S. W.; Jung, B. H.; Oh, S. H.; Lee, B. H. Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver J. Lipid Res. 2011, 52, 1617-1625 10.1194/jlr.M015263
42. Van Aller, G. S.; Carson, J. D.; Tang, W.; Peng, H.; Zhao, L.; Copeland, R. A.; Tummino, P. J.; Luo, L. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor Biochem. Biophys. Res. Commun. 2011, 406, 194-199 10.1016/j.bbrc.2011.02.010
43. Osborne, T. F. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action J. Biol. Chem. 2000, 275, 32379-32382 10.1074/jbc.R000017200
44. Klaus, S.; Pultz, S.; Thone-Reineke, C.; Wolfram, S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation Int. J. Obes. 2005, 29, 615-623 10.1038/sj.ijo.0802926